Wafra Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-88,951
Closed -$13M 98
2017
Q3
$13M Sell
88,951
-70,970
-44% -$9.67M 0.63% 36
2017
Q2
$20.8M Sell
159,921
-16,453
-9% -$2.02M 1.05% 10
2017
Q1
$21.9M Sell
176,374
-16,638
-9% -$1.99M 1.13% 9
2016
Q4
$22.3M Sell
193,012
-622
-0.3% -$69.3K 1.21% 9
2016
Q3
$20.2M Hold
193,634
1.51% 12
2016
Q2
$19.1M Sell
193,634
-12,068
-6% -$1.25M 2.33% 11
2016
Q1
$20.6M Buy
205,702
+35,373
+21% +$3.64M 2.34% 15
2015
Q4
$20.4M Buy
170,329
+6,901
+4% +$798K 2.37% 15
2015
Q3
$17.7M Sell
163,428
-3,301
-2% -$410K 2.17% 17
2015
Q2
$19.3M Buy
166,729
+8,279
+5% +$946K 2.1% 18
2015
Q1
$18.3M Hold
158,450
1.91% 22
2014
Q4
$17.7M Buy
+158,450
New +$16.7M 1.83% 26
2014
Q1
Sell
-167,700
Closed -$14.2M 87
2013
Q4
$14.2M Hold
167,700
1.81% 18
2013
Q3
$12.9M Hold
167,700
1.88% 18
2013
Q2
$9.81M Buy
+167,700
New +$10.1M 1.56% 27

Other funds holding CELG

Wafra Inc's CELG Position: Q4 2017 in Review

Wafra Inc sold out of Celgene Corp (CELG) in Q4 2017, closing a stake of 88,951 shares — an estimated $13M sold.

Wafra Inc first reported a position in CELG in Q2 2013 and held it in 15 quarters. The position peaked at $22.3M in Q4 2016. 1,470 funds tracked by Wall St. Rank hold CELG as of Q4 2017.

  • Wafra Inc reported no remaining Celgene Corp position as of Q4 2017 after selling out during the quarter.
  • Wafra Inc sold 88,951 Celgene Corp shares in Q4 2017, an estimated $13M.
  • Wafra Inc first reported a position in Celgene Corp in Q2 2013 and held it in 15 quarters.
  • Wafra Inc's Celgene Corp position peaked at $22.3M in Q4 2016.
  • 1,470 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2017.

Based on Wafra Inc's 13F filing for Q4 2017, filed 14 Feb 2018.